FLUIDIGM CORP (FLDM) Stock Price & Overview
NASDAQ:FLDM
Current stock price
The current stock price of FLDM is 3.71 null. Today FLDM is down by -7.02%. In the past month the price increased by 8.8%. In the past year, price decreased by -19.35%.
FLDM Key Statistics
- Market Cap
- 285.369M
- P/E
- N/A
- Fwd P/E
- N/A
- EPS (TTM)
- -0.78
- Dividend Yield
- N/A
FLDM Stock Performance
FLDM Stock Chart
FLDM Technical Analysis
ChartMill assigns a technical rating of 5 / 10 to FLDM. When comparing the yearly performance of all stocks, FLDM turns out to be only a medium performer in the overall market: it outperformed 66.04% of all stocks.
FLDM Fundamental Analysis
ChartMill assigns a fundamental rating of 1 / 10 to FLDM. FLDM may be in some trouble as it scores bad on both profitability and health.
FLDM Earnings
FLDM Forecast & Estimates
7 analysts have analysed FLDM and the average price target is 6.12 null. This implies a price increase of 64.96% is expected in the next year compared to the current price of 3.71.
For the next year, analysts expect an EPS growth of -30.77% and a revenue growth -0.48% for FLDM
FLDM Groups
Sector & Classification
FLDM Financial Highlights
Over the last trailing twelve months FLDM reported a non-GAAP Earnings per Share(EPS) of -0.78. The EPS decreased by -6.85% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | -45.36% | ||
| ROA | -21.52% | ||
| ROE | N/A | ||
| Debt/Equity | 0.68 |
FLDM Ownership
FLDM Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| TMO | THERMO FISHER SCIENTIFIC INC | 21.2 | 195.48B | ||
| DHR | DANAHER CORP | 23.02 | 138.355B | ||
| BRKRP | BRUKER CORP - BRKR 6 3/8 09/01/28 | 148.14 | 48.731B | ||
| A | AGILENT TECHNOLOGIES INC | 18 | 34.183B | ||
| WAT | WATERS CORP | 23.08 | 32.947B | ||
| IQV | IQVIA HOLDINGS INC | 13.78 | 29.673B | ||
| MTD | METTLER-TOLEDO INTERNATIONAL | 28.21 | 26.824B | ||
| ILMN | ILLUMINA INC | 25.39 | 20.183B | ||
| WST | WEST PHARMACEUTICAL SERVICES | 34.28 | 20.038B | ||
| MEDP | MEDPACE HOLDINGS INC | 30.27 | 15.092B | ||
| RVTY | REVVITY INC | 16.9 | 10.401B | ||
| TEM | TEMPUS AI INC-CL A | N/A | 10.186B | ||
| TECH | BIO-TECHNE CORP | 27.27 | 9.478B |
Related stock screener links
View all stocks in the Life Sciences Tools & Services Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About FLDM
Company Profile
Fluidigm Corp. is engaged in the development, manufacture, and marketing of biotechnology tools for life sciences research. The company is headquartered in South San Francisco, California and currently employs 615 full-time employees. The company went IPO on 2011-02-10. The firm operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. The company markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits (ifcs), assays, and reagents. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.
Company Info
IPO: 2011-02-10
FLUIDIGM CORP
2 Tower Place, Suite 2000
South San Francisco CALIFORNIA 94080 US
CEO: Stephen Christopher Linthwaite
Employees: 615
Phone: 16502666000.0
FLUIDIGM CORP / FLDM FAQ
What does FLUIDIGM CORP do?
Fluidigm Corp. is engaged in the development, manufacture, and marketing of biotechnology tools for life sciences research. The company is headquartered in South San Francisco, California and currently employs 615 full-time employees. The company went IPO on 2011-02-10. The firm operates in development, manufacturing, and commercialization of tools for life sciences research. Its technology, mass cytometry is a multiplexed solution to analyze cell-surface and intracellular proteins simultaneously in cell suspensions including blood and disassociated tissues. Its Imaging Mass Cytometry (IMC) technology allows multiplexed imaging to understand the composition of tissue microenvironments at a subcellular 1-micron resolution. The company markets technologies and life science tools, including preparatory and analytical instruments for mass cytometry, library prep, single cell genomics, and consumables, including integrated fluidic circuits (ifcs), assays, and reagents. Its analytical instruments include Biomark HD System, EP1 System, and Hyperion Tissue Imager.
What is the stock price of FLUIDIGM CORP today?
The current stock price of FLDM is 3.71 null. The price decreased by -7.02% in the last trading session.
Does FLDM stock pay dividends?
FLDM does not pay a dividend.
How is the ChartMill rating for FLUIDIGM CORP?
FLDM has a ChartMill Technical rating of 5 out of 10 and a ChartMill Fundamental rating of 1 out of 10.
On which exchange is FLDM stock listed?
FLDM stock is listed on the Nasdaq exchange.
Can you provide the PE ratio for FLDM stock?
FLUIDIGM CORP (FLDM) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.78).
What is the market capitalization of FLDM stock?
FLUIDIGM CORP (FLDM) has a market capitalization of 285.37M null. This makes FLDM a Micro Cap stock.